Auxano Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $753K | Buy |
4,056
+35
| +0.9% | +$6.5K | 0.18% | 74 |
|
2025
Q1 | $842K | Buy |
4,021
+519
| +15% | +$109K | 0.22% | 65 |
|
2024
Q4 | $622K | Sell |
3,502
-429
| -11% | -$76.2K | 0.16% | 85 |
|
2024
Q3 | $776K | Buy |
3,931
+502
| +15% | +$99.1K | 0.2% | 80 |
|
2024
Q2 | $588K | Sell |
3,429
-168
| -5% | -$28.8K | 0.16% | 89 |
|
2024
Q1 | $655K | Buy |
3,597
+1,313
| +57% | +$239K | 0.19% | 83 |
|
2023
Q4 | $354K | Sell |
2,284
-101
| -4% | -$15.7K | 0.12% | 101 |
|
2023
Q3 | $356K | Hold |
2,385
| – | – | 0.15% | 73 |
|
2023
Q2 | $380K | Hold |
2,385
| – | – | 0.15% | 72 |
|
2023
Q1 | $380K | Hold |
2,385
| – | – | 0.15% | 72 |
|
2022
Q4 | $385K | Hold |
2,385
| – | – | 0.17% | 68 |
|
2022
Q3 | $320K | Buy |
+2,385
| New | +$320K | 0.15% | 72 |
|
2022
Q2 | – | Sell |
-1,267
| Closed | -$205K | – | 80 |
|
2022
Q1 | $205K | Buy |
+1,267
| New | +$205K | 0.09% | 78 |
|